@article{1099b2326a084e28b0376c0e902c84e6,
title = "Adapting Head and Neck Cancer Management in the Time of COVID-19",
author = "{the Head and Neck International Group (HNCIG)} and Hisham Mehanna and Maura Gillison and Lee, {Anne W.M.} and {von Zeidler}, {Sandra V.} and Sandro Porceddu",
note = "Funding Information: Disclosures: H.M. reports personal fees from MSD, Sanofi Pasteur, and Merck; grants from GSK Biologicals, AstraZeneca, and GSK PLC; and other from Warwickshire Head Neck Clinic Ltd, and MSD, outside the submitted work. H.M. is a National Institute for Health Research senior investigator. The views expressed in this article are those of the author(s) and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. ",
year = "2020",
month = jul,
day = "15",
doi = "10.1016/j.ijrobp.2020.04.017",
language = "English (US)",
volume = "107",
pages = "628--630",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",
}